- CEO
- Na Sun
- Full Time Employees
- 869
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Harbin China
- IPO Date
- Aug 1, 2023
- Business
- Harbin Fuerjia Technology Co., Ltd. is a China-based company primarily engaged in the research, development, production, and commercialization of professional skin care products and medical dressings. The company operates across two core business segments: Medical Device Dressings and Functional Cosmetics. Its comprehensive product portfolio comprises medical-grade skin repair dressings, including medical sodium hyaluronate repair dressings, recombinant collagen wound repair patches, medical skin repair liquids, and silicone scar treatment gels; functional facial masks, including deep hydrating, barrier repair, acne treatment, soothing, and anti-aging sheet masks; and specialized skincare formulations, including restorative essences, intensive serums, moisturizing lotions, facial creams, amino acid cleansers, freeze-dried active powder sets, and sun protection emulsions, marketed primarily under the flagship Fuerjia brand. Harbin Fuerjia Technology distributes its products nationwide across the People's Republic of China, serving medical aesthetic institutions, dermatology departments, retail pharmacy chains, beauty specialty stores, and consumers through major online e-commerce platforms and livestreaming retail channels. Founded in 2017 and headquartered in Harbin, Heilongjiang Province, the company completed its initial public offering on the Shenzhen Stock Exchange ChiNext board. In recent operational developments, the company commissioned its large-scale intelligent manufacturing industrial park in Harbin, expanding automated in-house production capacity for both medical devices and cosmetics formulations. Furthermore, Harbin Fuerjia has strategically broadened its technological pipeline through collaborative research partnerships focusing on recombinant collagen biomaterials and active peptide synthesis, launched next-generation recombinant type III collagen skin-repair product lines, and optimized its omnichannel supply chain and direct-to-consumer distribution infrastructure.